Loading...

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation

In patients with chronic lymphocytic leukemia (CLL), persistence of disease after allogeneic stem cell transplantation (alloSCT) can result in poor outcomes. In an effort to improve these outcomes, patients with persistent CLL who were 90–100 days post alloSCT with no evidence of graft-versus-host-d...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Biol Blood Marrow Transplant
Main Authors: Khouri, Maria R., Jabbour, Elias J., Gulbis, Alison M., Turturro, Francesco, Ledesma, Celina, Korbling, Martin, Samuels, Barry I., Ahmed, Sairah, Alousi, Amin M., Ciurea, Stefan O., Marin, David, Patel, Krina K., Popat, Uday R., Bueso-Ramos, Carlos E., Bassett, Roland L., Khouri, Issa F.
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141702/
https://ncbi.nlm.nih.gov/pubmed/28495642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.04.027
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!